KCND2 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with KCND2 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with KCND2 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with KCND2 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KCND2 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000162368 - cytidine/uridine monophosphate kinase 1

Gene

ENSG00000147224 - phosphoribosyl pyrophosphate synthetase 1

Gene

ENSG00000186153 - WW domain containing oxidoreductase

Gene

ENSG00000204308 - ring finger protein 5

Gene

ENSG00000011523 - centrosomal protein 68

Gene

ENSG00000196678 - ERI1 exoribonuclease family member 2

Gene

ENSG00000132514 - C-type lectin domain containing 10A

Gene

ENSG00000162267 - inter-alpha-trypsin inhibitor heavy chain 3

  • Gene

    ENSG00000162368 - cytidine/uridine monophosphate kinase 1


  • Gene

    ENSG00000147224 - phosphoribosyl pyrophosphate synthetase 1


  • Gene

    ENSG00000186153 - WW domain containing oxidoreductase


  • Gene

    ENSG00000204308 - ring finger protein 5


  • Gene

    ENSG00000011523 - centrosomal protein 68


  • Gene

    ENSG00000196678 - ERI1 exoribonuclease family member 2


  • Gene

    ENSG00000132514 - C-type lectin domain containing 10A


  • Gene

    ENSG00000162267 - inter-alpha-trypsin inhibitor heavy chain 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.